Skip to main
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc is strategically positioned to capitalize on the anticipated stronger Medicare Advantage (MA) rate update for 2026, especially as many managed care organizations are reducing benefits, while Alignment Healthcare gains a funding advantage through its Stars rating. The company's integrated MA-Value-Based Care (VBC) model is expected to drive long-term market share growth and above-average revenue expansion. Additionally, projected gross profit per member per month (PMPM) for initial cohorts ranges between $90-$150, increasing to over $230 PMPM in later years, indicating a positive margin maturation trajectory that could enhance financial performance.

Bears say

Alignment Healthcare Inc's performance indicators suggest potential challenges, particularly as the company operates within a high healthcare utilization environment post-COVID and while navigating complexities associated with value-based care (VBC). Despite demonstrating above-average EBITDA growth and achieving a lower Adjusted Days of Care (ADK) during a time when healthcare needs were rising, the firm faces data friction and inconsistencies in results across various payors and physician groups which may hinder sustainable performance. Additionally, the valuation multiples slightly exceeding the long-term range for peer managed care organizations may indicate an overvaluation relative to the risks presented by operational challenges inherent in their care delivery model.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Jan 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.